Literature DB >> 32114203

Post tuberculosis treatment infectious complications.

Desmond Hsu1, Muhammad Irfan2, Kauser Jabeen3, Nousheen Iqbal4, Rumina Hasan5, Giovanni Battista Migliori6, Alimuddin Zumla7, Dina Visca8, Rosella Centis9, Simon Tiberi10.   

Abstract

Following greater attention and follow-up of patients with treated pulmonary tuberculosis (TB), it has emerged that infections are more likely to occur in this cohort of patients. This comes as no surprise, as pulmonary TB is a destructive process that leads to cicatrization, alteration of parenchyma, bronchiectasis, and scarring of the lung, with reduction of lung volumes and an impact on pulmonary function. In addition to relapse and re-infection with TB, other pathogens are increasingly recognized in post-TB patients. This paper serves as a summary and guide on how to approach the post-TB patient with new signs and symptoms of pulmonary infection in order to ensure optimal management and rehabilitation.
Copyright © 2020. Published by Elsevier Ltd.

Entities:  

Keywords:  Bronchiectasis; NTM; Post-treatment complication; Pulmonary rehabilitation; Sequelae; Tuberculosis

Mesh:

Year:  2020        PMID: 32114203     DOI: 10.1016/j.ijid.2020.02.032

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  9 in total

Review 1.  The COVID-19 and TB syndemic: the way forward.

Authors:  A Trajman; I Felker; L C Alves; I Coutinho; M Osman; S-A Meehan; U B Singh; Y Schwartz
Journal:  Int J Tuberc Lung Dis       Date:  2022-08-01       Impact factor: 3.427

2.  Clinical standards for the assessment, management and rehabilitation of post-TB lung disease.

Authors:  G B Migliori; F M Marx; N Ambrosino; E Zampogna; H S Schaaf; M M van der Zalm; B Allwood; A L Byrne; K Mortimer; R S Wallis; G J Fox; C C Leung; J M Chakaya; B Seaworth; A Rachow; B J Marais; J Furin; O W Akkerman; F Al Yaquobi; A F S Amaral; S Borisov; J A Caminero; A C C Carvalho; D Chesov; L R Codecasa; R C Teixeira; M P Dalcolmo; S Datta; A-T Dinh-Xuan; R Duarte; C A Evans; J-M García-García; G Günther; G Hoddinott; S Huddart; O Ivanova; R Laniado-Laborín; S Manga; K Manika; A Mariandyshev; F C Q Mello; S G Mpagama; M Muñoz-Torrico; P Nahid; C W M Ong; D J Palmero; A Piubello; E Pontali; D R Silva; R Singla; A Spanevello; S Tiberi; Z F Udwadia; M Vitacca; R Centis; L D Ambrosio; G Sotgiu; C Lange; D Visca
Journal:  Int J Tuberc Lung Dis       Date:  2021-10-01       Impact factor: 3.427

Review 3.  The Microbiome as Part of the Contemporary View of Tuberculosis Disease.

Authors:  Martín Barbosa-Amezcua; David Galeana-Cadena; Néstor Alvarado-Peña; Eugenia Silva-Herzog
Journal:  Pathogens       Date:  2022-05-16

4.  Impact of COVID-19 on TB active case finding in Nigeria.

Authors:  B Odume; V Falokun; O Chukwuogo; C Ogbudebe; S Useni; N Nwokoye; E Aniwada; B Olusola Faleye; I Okekearu; D Nongo; T Odusote; A Lawanson
Journal:  Public Health Action       Date:  2020-12-21

Review 5.  Mycobacterium tuberculosis and Pulmonary Rehabilitation: From Novel Pharmacotherapeutic Approaches to Management of Post-Tuberculosis Sequelae.

Authors:  Andreea-Daniela Meca; Liliana Mititelu-Tarțău; Maria Bogdan; Lorena Anda Dijmarescu; Ana-Maria Pelin; Liliana Georgeta Foia
Journal:  J Pers Med       Date:  2022-04-02

Review 6.  Clinical Outcomes of Individuals with COVID-19 and Tuberculosis during the Pre-Vaccination Period of the Pandemic: A Systematic Review.

Authors:  Tulip A Jhaveri; Celia Fung; Allison N LaHood; Andrew Lindeborg; Chengbo Zeng; Rifat Rahman; Paul A Bain; Gustavo E Velásquez; Carole D Mitnick
Journal:  J Clin Med       Date:  2022-09-26       Impact factor: 4.964

Review 7.  A Pandemic within Other Pandemics. When a Multiple Infection of a Host Occurs: SARS-CoV-2, HIV and Mycobacterium tuberculosis.

Authors:  Carmen María González-Domenech; Isabel Pérez-Hernández; Cristina Gómez-Ayerbe; Isabel Viciana Ramos; Rosario Palacios-Muñoz; Jesús Santos
Journal:  Viruses       Date:  2021-05-17       Impact factor: 5.048

8.  TB or not TB? Definitive determination of species within the Mycobacterium tuberculosis complex in unprocessed sputum from adults with presumed multidrug-resistant tuberculosis.

Authors:  Peter M Mbelele; Elingarami Sauli; Emmanuel A Mpolya; Sagal Y Mohamed; Kennedy K Addo; Sayoki G Mfinanga; Scott K Heysell; Stellah Mpagama
Journal:  Trop Med Int Health       Date:  2021-06-24       Impact factor: 3.918

Review 9.  Mesenchymal Stem Cells and Tuberculosis: Clinical Challenges and Opportunities.

Authors:  Xueying Zhang; Qi Xie; Ziyu Ye; Yanyun Li; Zhengping Che; Mingyuan Huang; Jincheng Zeng
Journal:  Front Immunol       Date:  2021-07-22       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.